Brief: Tarsus And John Cena Partner To Raise Awareness Of Demodex Blepharitis, A Common Eyelid Disease Affecting Approximately 25 Million Americans
14/05/2026 13:36
May 14 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O: TARSUS AND JOHN CENA PARTNER TO RAISE AWARENESS OF DEMODEX BLEPHARITIS, A COMMON EYELID DISEASE AFFECTING APPROXIMATELY 25 MILLION AMERICANS Source text: ID:nGNX3H4bTw Further company coverage: TARS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)